Skip to content
Every compound links to batch-tested stock at Nordapep, with a Certificate of Analysis per batch.
peptide.wiki

Mazdutide

Mazdutide is an oxyntomodulin-based peptide that activates the GLP-1 and glucagon receptors. It has been approved for obesity in China but not by the MHRA, EMA or FDA.

Approved in ChinaMetabolic & incretin researchGLP-1 and glucagon receptor dual agonist, approved in China4/54/5

At a glance

4/54/5
Class
Dual GLP-1 / glucagon receptor agonist (oxyntomodulin analogue)
Receptor targets
GLP-1R, GCGR
Length
Modified oxyntomodulin-based peptide (fatty-acid conjugated)
Molecular mass
Not fully published (large acylated peptide, several kDa)
Origin
Synthetic, oxyntomodulin-based sequence
Research area
Metabolic & incretin research
Also known as
IBI362, LY3305677

What Mazdutide is

Mazdutide originated in Eli Lilly's GLP-1/glucagon co-agonist research and was developed in China by Innovent Biologics as IBI362. It is an analogue of oxyntomodulin, a natural gut hormone that activates both the GLP-1 and glucagon receptors.

Its main research interest is the glucagon component, which is studied for its effects on energy expenditure and liver fat alongside the appetite-related GLP-1 signal. Most published human data come from Chinese study populations.

What the research literature studies

  • GLP-1 and glucagon receptor signalling in cell-based assays
  • Oxyntomodulin analogues and the role of glucagon-receptor activity in rodent models
  • Identity and purity analysis of a large modified peptide (HPLC and intact mass)

Evidence rating: 4/5

Late-stage human trials. Phase 3 data from Chinese populations and a regional approval. Limited data outside China. See our methodology for how levels are assigned.

  • Human data are concentrated in Chinese study populations and may not generalise.
  • Head-to-head evidence against other incretin peptides is still limited.

Regulatory status

Mazdutide has been approved by China's NMPA for obesity. It has not been approved by the MHRA, EMA or FDA. Research material is not that medicine and must not be used in people or animals.

Reviewed November 2026.

Mazdutide at Nordapep: sizes and price per mg

Every size, its price and the cost per milligram, so you can choose the best-value vial for your protocol.

Not currently listed at Nordapep.

Compare Mazdutide

Mazdutide FAQ

Is mazdutide the same as survodutide?

No. Both activate the GLP-1 and glucagon receptors, but they are different molecules from different developers, with different backbones and different regulatory histories.

Is mazdutide approved in the UK or EU?

No. It has a regional approval in China only. Research-grade material is for in vitro laboratory work only.

Where can I buy Mazdutide for research?

Nordapep does not currently list Mazdutide. You can ask Nordapep about availability, or compare related compounds that are in stock.

Is Mazdutide approved?

Mazdutide has been approved by China's NMPA for obesity. It has not been approved by the MHRA, EMA or FDA. Research material is not that medicine and must not be used in people or animals.

Key terms for Mazdutide

Cite this page

peptide.wiki. (2026). Mazdutide: research peptide profile. peptide.wiki. https://www.peptide.wiki/peptides/mazdutide
Free to cite and link. Last reviewed November 2026.
For laboratory research only. Nothing on peptide.wiki is medical advice. The compounds described are not for human or veterinary use, and research-grade material is not a medicine.

Related compounds